New York Times: Trump administration officials passed when Pfizer offered in late summer to sell the U.S. more vaccine doses
New York Times said:Trump administration officials passed when Pfizer offered in late summer to sell the U.S. government additional doses of its Covid-19 vaccine, according to people familiar with the matter. Now Pfizer may not be able provide more of its vaccine to the United States until next June because of its commitments to other countries, they said.
That included whether it would expand the U.S. supply of doses beyond what is spelled out in existing federal contracts.
The vaccine being produced by Pfizer and its German partner, BioNTech, is a two-dose treatment, meaning that 100 million doses is enough to vaccinate only 50 million Americans. The vaccine is expected to receive authorization for emergency use in the U.S. as soon as this weekend, with another vaccine, developed by Moderna, also likely to be approved for emergency use soon.